$1.16
0.010.87%
At Close: -
15 minutes delayed
Comments
Loading...
Protalix BioTherapeutics (AMEX:PLX) Stock, Earnings Estimates, EPS, And Revenue
Protalix BioTherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 9
EPS Estimate
$0.020
Quarterly Revenue Estimate
$12.5M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$59.7M
Analyze the earnings history of Protalix BioTherapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics | $0.21 | $0.02 | — | — | $35.08M | $12.50M | — | — | 08/09/2024 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.05 | -$0.02 | -$0.06 | -200.00% | $9.59M | $9.20M | $3.75M | -59.26% | 05/10/2024 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.07 | -$0.03 | -$0.07 | -133.33% | $8.62M | $5.80M | $10.49M | 80.79% | 03/14/2024 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.07 | -$0.04 | -$0.04 | 0.00% | $14.18M | $10.00M | $10.35M | 3.45% | 11/06/2023 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.11 | -$0.04 | $0.21 | 625.00% | $8.75M | $10.22M | $35.08M | 243.20% | 08/07/2023 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.05 | — | -$0.05 | — | $16.09M | — | $9.59M | — | 05/04/2023 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.14 | -$0.15 | -$0.07 | 53.33% | $8.55M | $6.12M | $8.62M | 40.80% | 02/27/2023 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.09 | -$0.15 | -$0.07 | 53.33% | $12.05M | $14.18M | $14.18M | 0.00% | 11/14/2022 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.25 | -$0.18 | -$0.11 | 38.89% | $6.43M | — | $8.75M | — | 08/15/2022 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.14 | -$0.05 | -$0.05 | 0.00% | $11.32M | $15.50M | $16.09M | 3.77% | 05/16/2022 | Get Alert |
| PLX | Protalix BioTherapeutics | $0.03 | -$0.11 | -$0.14 | -27.27% | $19.50M | $7.79M | $8.55M | 9.74% | 03/31/2022 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.14 | -$0.11 | -$0.09 | 18.18% | $10.79M | $7.79M | $12.05M | 54.74% | 11/15/2021 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.13 | -$0.08 | -$0.25 | -212.50% | $10.97M | $8.30M | $6.43M | -22.57% | 08/16/2021 | Get Alert |
| PLX | Protalix BioTherapeutics | $0.10 | -$0.17 | -$0.14 | 17.65% | $21.65M | $10.95M | $11.32M | 3.38% | 05/14/2021 | Get Alert |
| PLX | Protalix BioTherapeutics | $0.02 | -$0.08 | $0.03 | 137.50% | $3.78M | $11.99M | $19.50M | 62.59% | 03/30/2021 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.20 | -$0.17 | -$0.14 | 17.65% | $14.25M | $10.08M | $10.79M | 7.04% | 10/29/2020 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.50 | -$0.20 | -$0.13 | 35.00% | $12.25M | $10.87M | $10.97M | 0.89% | 08/10/2020 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.50 | -$0.30 | $0.10 | 133.33% | $10.44M | $6.60M | $21.65M | 227.97% | 06/01/2020 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.30 | — | $0.02 | — | $10.35M | $12.85M | $3.78M | -70.58% | 03/12/2020 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.40 | -$0.30 | -$0.20 | 33.33% | $663.00K | $11.60M | $14.25M | 22.83% | 11/07/2019 | Get Alert |
| PLX | Protalix BioTherapeutics | -$0.60 | -$0.30 | -$0.50 | -66.67% | $2.01M | $11.75M | $12.25M | 4.23% | 08/08/2019 | Get Alert |
Protalix BioTherapeutics (PLX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-10 | $-0.06 | $-0.02 | -200.0 % |
| Dec 2023 | 2024-03-14 | $-0.07 | $-0.03 | -133.3 % |
| Sep 2023 | 2023-11-06 | $-0.04 | $-0.04 | 0.00 % |
| Jun 2023 | 2023-08-07 | $0.21 | $-0.04 | 625.0 % |
Protalix BioTherapeutics (PLX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-10 | $3.75M | $9.20M | -59.3 % |
| Dec 2023 | 2024-03-14 | $10.49M | $5.80M | 80.8 % |
| Sep 2023 | 2023-11-06 | $10.35M | $10.00M | 3.45 % |
| Jun 2023 | 2023-08-07 | $35.08M | $10.22M | 243.2 % |
FAQ
When is Protalix BioTherapeutics (AMEX:PLX) reporting earnings?
Protalix BioTherapeutics (PLX) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on May 10, 2024 for Q1.
What were the latest earnings per share (EPS) for Protalix BioTherapeutics (AMEX:PLX)?
The Actual EPS was $-0.06, which missed the estimate of $-0.02.
What were Protalix BioTherapeutics’s (AMEX:PLX) revenues?
The Actual Revenue was $3.7M, which missed the estimate of $9.2M.
Browse earnings estimates, EPS, and revenue on all stocks.